IDH mutations in murine models of glioma led to disease progression with the associated upregulated D-2HG led to global hypermethylation, establishing a phenotype in gliomas called glioma CpG island methylator phenotype [33]. This evidence concerns the gene IDH1 and central nervous system cancer.